# SAB Biotherapeutics (SABS) — Earnings

SABS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sabs/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.27 |
| EPS estimate | −$0.28 |
| EPS surprise | +4.59% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1833214/000119312526336783/sabs-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/2a715ca5-b0d8-ac55-ebff-0944205f5361.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.28 | −$0.27 | 4.59% | — | — |
| Q1 2026 | May 12, 2026 | −$0.29 | −$0.35 | -22.04% | — | — |
| Q2 2025 | Aug 7, 2025 | −$0.80 | −$1.09 | -36.93% | $125,000.00 | — |
| Q1 2025 | May 9, 2025 | −$1.07 | −$0.56 | 47.79% | $125,000.00 | — |
| Q4 2024 | Mar 31, 2025 | −$1.16 | −$1.23 | -5.67% | $120,000.00 | $100,000.00 |
| Q3 2024 | Nov 6, 2024 | −$1.11 | −$1.12 | -1.27% | $120,000.00 | — |
| Q2 2024 | Aug 8, 2024 | −$1.15 | −$0.79 | 31.11% | — | $300,000.00 |
| Q1 2024 | May 20, 2024 | −$0.96 | −$0.54 | 43.75% | — | $944,575.00 |
| Q4 2023 | Mar 29, 2024 | −$0.62 | −$3.38 | -445.16% | — | $300,000.00 |
| Q3 2023 | Nov 13, 2023 | −$1.17 | −$1.00 | 14.29% | $11,966.00 | $633,500.00 |
| Q2 2022 | Aug 10, 2022 | −$1.30 | −$1.10 | 15.38% | $10.8M | $6.4M |
| Q1 2022 | May 12, 2022 | −$1.43 | $0.20 | 113.95% | $11.5M | $11.8M |

## Frequently Asked Questions

### When did SAB Biotherapeutics (SABS) last report earnings?

SAB Biotherapeutics last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did SABS beat earnings estimates?

Yes. SAB Biotherapeutics reported EPS of −$0.27 for Q2 2026 against a −$0.28 estimate — a 4.59% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).